Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: 54Gene, Inc. · Sector: Healthcare, Biotechnology · Countries of operation: Nigeria
Transaction type: Exit · Asset class: Venture Capital
Sellers: Future Africa
Legal advisers: not identified in the source record.
Announcement date not disclosed in the source; listed under 2026 for indexing. Original announcement: link.


